Perletti, G. (2016) “Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer”, Archivio Italiano di Urologia e Andrologia, 88(1), pp. 74-75. doi: 10.4081/aiua.2016.1.74.